Authors
Loading...
Clinical trial shows cryopreserved hematopoietic progenitor cells effectively prevent relapse in HLA-mismatched transplants, indicating promise for future therapies.
Jeremy Pantin (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: